Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 3 |
2022 | 2 |
2024 | 0 |
PubMed for id: 222418596
6 results
Results by year
Filters applied: . Clear all
Page 1
Downregulation of lncRNA ASMTL-AS1 in Epithelial Ovarian Cancer Correlates with Worse Prognosis and Cancer Progression.
Horm Metab Res. 2022 Jul;54(7):481-488. doi: 10.1055/a-1872-0546. Epub 2022 Jul 14.
Horm Metab Res. 2022.
PMID: 35835145
LncRNA ASMTL-AS1/microRNA-1270 differentiate prognostic groups in gastric cancer and influence cell proliferation, migration and invasion.
Song Z, Wang J.
Song Z, et al.
Bioengineered. 2022 Jan;13(1):1507-1517. doi: 10.1080/21655979.2021.2021063.
Bioengineered. 2022.
PMID: 34986743
Free PMC article.
Item in Clipboard
ASMTL-AS1 impedes the malignant progression of lung adenocarcinoma by regulating SAT1 to promote ferroptosis.
Sui X, Hu N, Zhang Z, Wang Y, Wang P, Xiu G.
Sui X, et al.
Pathol Int. 2021 Nov;71(11):741-751. doi: 10.1111/pin.13158. Epub 2021 Oct 18.
Pathol Int. 2021.
PMID: 34658100
Item in Clipboard
Long non-coding RNA ASMTL-AS1 deteriorates the oncogenicity of osteosarcoma by decoying microRNA-342-3p and consequently raising ADAM9 expression.
Hou C, Sun F, Sun M.
Hou C, et al.
Biochem Biophys Res Commun. 2021 Nov 19;579:89-96. doi: 10.1016/j.bbrc.2021.09.049. Epub 2021 Sep 22.
Biochem Biophys Res Commun. 2021.
PMID: 34597997
Item in Clipboard
A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer.
Sun J, Li X, Yu E, Liu J, Sun L, He Q, Lu Q.
Sun J, et al.
Diagn Pathol. 2021 May 18;16(1):45. doi: 10.1186/s13000-021-01105-3.
Diagn Pathol. 2021.
PMID: 34006305
Free PMC article.
Item in Clipboard
Exosome-transferred long non-coding RNA ASMTL-AS1 contributes to malignant phenotypes in residual hepatocellular carcinoma after insufficient radiofrequency ablation.
Ma D, Gao X, Liu Z, Lu X, Ju H, Zhang N.
Ma D, et al.
Cell Prolif. 2020 Sep;53(9):e12795. doi: 10.1111/cpr.12795. Epub 2020 Jul 28.
Cell Prolif. 2020.
PMID: 32722884
Free PMC article.
Item in Clipboard
Cite
Cite